Biological activities of 2α-substituted analogues of 1α,25-dihydroxyvitamin D3 in transcriptional regulation and human promyelocytic leukemia (HL-60) cell proliferation and differentiation

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 11, 2006, Pages 2246-2250

  Takahashi, Eiji ^a   Nakagawa, Kimie ^a   Suhara, Yoshitomo ^a   Kittaka, Atsushi ^b   Nihei, Ken Ichi ^b   Konno, Katsuhiro ^b   Takayama, Hiroaki ^b   Ozono, Keiichi ^c   Okano, Toshio ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

1 ,25 dihydroxyvitamin D3; 2 substituted analogue; Cell cycle arrest; Cell differentiation; Gene transactivation

Indexed keywords

1 ALPHA,25 DIHYDROXYVITAMIN D3; CALCIFEDIOL; CALCITRIOL; CD11B ANTIGEN; CD14 ANTIGEN; DIHYDROXYCOLECALCIFEROL; OSTEOCALCIN; TRANSCRIPTION FACTOR GAL4; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; DRUG DERIVATIVE; LUCIFERASE; STEROID MONOOXYGENASE; VITAMIN D 24 HYDROXYLASE; VITAMIN D 24-HYDROXYLASE;

ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; RAT; THYMUS; TRANSCRIPTION INITIATION; ANIMAL; BIOSYNTHESIS; CATTLE; CELL STRAIN HL 60; CHEMICAL STRUCTURE; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROTEIN BINDING; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD14; CALCITRIOL; CATTLE; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; LUCIFERASES; MOLECULAR STRUCTURE; OSTEOCALCIN; PROTEIN BINDING; RATS; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS); TRANSFECTION; VITAMIN D-BINDING PROTEIN;

EID: 33750624588     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.2246     Document Type: Article

References (33)

1. Pike J. W., Annu. Rev. Nutr., 11, 189-216 (1991).
2. Evans R. M., Science, 240, 889-895 (1988).
3. Umesono K., Murakami K. K., Thompson C. C., Evans R. M., Cell, 65, 1255-1266 (1991).
4. Liao J., Ozono K., Sone T., McDonnel D. P., Pike J. W., Proc. Natl. Acad. Sci. U.S.A., 87, 9751-9755 (1990).
5. Ozono K., Liao J., Kerner S. A., Scott R. A., Pike J. W., J. Biol. Chem., 265, 21881-21888 (1990).
6. Palmieri G. M., J. Clin. Endocrinol. Metab., 82, 3516-3517 (1997).
7. Bikle D. D., Endocr. Rev., 13, 765-784 (1992).
8. Reichrath J., Perez A., Muller S. M., Chen T. C., Kerber A., Bahmer F. A., Holick M. F., Acta Derm. Venereol., 77, 268-272 (1997).
9. Snyman J. R., De Sommers K., Steinmann M. A., Lizamore D. J., J. Clin. Pharmacol., 52, 277-280 (1997).
10. Bishop J. E., Collins E. D., Okamura W. H., Norman A. W., J. Bone Miner. Res., 9, 1277-1288 (1994).
11. Bouillon R., Okamura W. H., Norman A. W., Endocr. Rev., 16, 200-257 (1995).
12. Konno K., Fujishima T., Maki S., Liu Z., Miura D., Chokki M., Ishizuka S., Yamaguchi K., Kan Y., Kurihara M., Miyata N., Smith C., DeLuca H. F., Takayama H., J. Med. Chem., 43, 4247-4265 (2000).
13. Ryhanen S., Mahonen A., Jaaskelainen T., Maenpaa P. H., Eur. J. Biochem., 238, 97-103 (1996).
14. Honzawa S., Suhara Y., Nihei K., Saito N., Kishimoto S., Fujishima T., Kurihara M., Sugiura T., Waku K., Takayama H., Kittaka A., Bioorg. Med. Chem. Lett., 13, 3503-3506 (2003).
15. Fujishima T., Liu Z., Miura D., Chokki M., Ishizuka S., Konno K., Takayama H., Bioorg. Med. Chem. Lett., 8, 2145-2148 (1998).
16. Suhara Y., Nihei K., Tanigawa H., Fujishima T., Konno K., Nakagawa K., Okano T., Takayama H., Bioorg. Med. Chem. Lett., 10, 1129-1132 (2000).
17. Tsugawa N., Nakagawa K., Kurobe M., Ono Y., Kubodera N., Ozono K., Okano T., Biol. Pharm. Bull., 23, 66-71 (2000).
18. Abe E., Miyaura C., Sakagami H., Takeda M., Konno K., Yamazaki T., Yoshiki S., Suda T., Proc. Natl. Acad. Sci. U.S.A., 78, 4990-4994 (1981).
19. Miyaura C., Abe E., Kuribayashi T., Tanaka H., Konno K., Nishii Y., Suda T., Biochem. Biophys. Res. Commun., 102, 937-943 (1981).
20. Colston K. W., Mackay A. G., Jamas S. Y., Binderup L., Chander S., Coombes R. C., Biochem. Pharmacol., 44, 2273-2280 (1992).
21. Yamada S., Yamamoto K., Masuno H., Ohta M., J. Med. Chem., 41, 1467-1475 (1998).
22. Suhara Y., Nihei K., Kurihara M., Kittaka A., Yamaguchi K., Fujishima T., Konno K., Miyata N., Takayama H., J. Org. Chem., 66, 8760-8771 (2001).
23. Saito N., Suhara Y., Kurihara M., Fujishima T., Honzawa S., Takayanagi H., Kozono T., Matsumoto M., Ohmori M., Miyata N., Takayama H., Kittaka A., J. Org. Chem., 69, 7463-7471 (2004).
24. Norman A. W., Roberts P. A., Methods Enzymol., 67, 473-478 (1980).
25. Wecksler W. R., Norman A. W., Methods Enzymol., 67, 488-494 (1980).
26. Lopenz W. W., McCann R. O., Longiaru M., Cormier M. J., Proc. Natl. Acad. Sci. U.S.A., 88, 4438-4442 (1991).
27. Rochel N., Wurtz J. M., Mitschler A., Klaholz B., Moras D., Mol. Cell, 5, 173-179 (2000).
28. Hansen C. M., Binderup L., Hamberg K. J., Carlberg C., Front Biosci., 6, D820-D848 (2001).
29. Colston K. W., James S. Y., Pirianov G., Curr. Topics Steroid Res., 2, 141-156 (1999).
30. van den Bemd G. J. C. M., Pols H. A., van Leeuwen J. P. T. M., Curr. Pharm. Des., 6, 717-732 (2000).
31. Dilworth F. J., Calverley M. J., Makin H. L., Jones G., Biochem. Pharmacol., 47, 987-993 (1994).
32. Nakagawa K., Kawamura A., Kato S., Takeda E., Okano T., Carcinogenesis, 26, 429-440 (2005).
33. Nakagawa K., Sasaki Y., Kato S., Kubodera N., Okano T., Carcinogenesis, 26, 1044-1054 (2005).